Tag: Denali Therapeutics Inc.

DNLI Shares Experience Decline in Value

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Denali Therapeutics Inc shares valued at $30,471 were sold by SATO VICKI L on Apr 15 ’24. At $18.29 per share, SATO VICKI L sold 1,666 shares. The insider’s holdings dropped […]

Denali Therapeutics Inc [DNLI] Krognes Steve E. sells 92,500 Shares for $1.9 million

Denali Therapeutics Inc’s recent filing unveils that its Director Krognes Steve E. unloaded Company’s shares for reported $1.9 million on Apr 01 ’24. In the deal valued at $20.50 per share,92,500 shares were sold. As a result of this transaction, Krognes Steve E. now holds 47,341 shares worth roughly $0.86 million. Then, SATO VICKI L […]

DNLI’s short interest reaches 8.38 million shares on Mar 15, 2024

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Denali Therapeutics Inc shares valued at $1,896,250 were sold by Krognes Steve E. on Apr 01 ’24. At $20.50 per share, Krognes Steve E. sold 92,500 shares. The insider’s holdings dropped to 47,341 shares worth approximately $0.87 […]

Recent Insider Activity Suggests Potential Gains for Denali Therapeutics Inc (DNLI)

Denali Therapeutics Inc’s filing revealed that its Director Krognes Steve E. unloaded Company’s shares for reported $1.9 million on Apr 01 ’24. In the deal valued at $20.50 per share,92,500 shares were sold. As a result of this transaction, Krognes Steve E. now holds 47,341 shares worth roughly $0.92 million. Then, SATO VICKI L sold […]

Citigroup gives a Buy recommendation for Denali Therapeutics Inc (DNLI)

Denali Therapeutics Inc’s recently made public that its Director SATO VICKI L unloaded Company’s shares for reported $33487.0 on Mar 15 ’24. In the deal valued at $20.10 per share,1,666 shares were sold. As a result of this transaction, SATO VICKI L now holds 119,709 shares worth roughly $2.35 million. Then, SATO VICKI L sold […]